The organizers of the 2021 ASCO Annual Meeting (ASCO 2021) released the accepted abstracts on the 19th (local time), two weeks ahead of the virtual event that will be held next month, from June 4-8.

The ASCO meeting is considered one of the most important events for biopharmaceutical companies around the world in introducing the latest clinical data on anticancer drugs. Due to the COVID-19 pandemic, all schedules in the 5-day event, including its keynote lectures, poster sessions, and exhibitions will be held virtually, non-face-to-face, for the second consecutive year.

The abstracts of Korean biopharmaceutical companies including Yuhan Corporation, Hanmi Pharmaceutical, MedPacto, and Ge